Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Amlodipine Besylate Patent Expiration

Amlodipine Besylate was first introduced by Viatris Specialty Llc in its drug Norvasc on Jul 31, 1992. Other drugs containing Amlodipine Besylate are Norliqva, Amlodipine Besylate. 38 different companies have introduced drugs containing Amlodipine Besylate.


Amlodipine Besylate Patents

Given below is the list of patents protecting Amlodipine Besylate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Norliqva US11253474 Pharmaceutical solution of amlodipine Feb 24, 2041 Cmp Dev Llc
Norliqva US11458095 Pharmaceutical solution of amlodipine Feb 24, 2041 Cmp Dev Llc
Norliqva US11723866 Pharmaceutical solution of amlodipine Feb 24, 2041 Cmp Dev Llc
Norliqva US12005141 Pharmaceutical solution of amlodipine Feb 24, 2041 Cmp Dev Llc
Amlodipine Besylate US6828339 Amlodipine salt forms and processes for preparing them Nov 20, 2022

(Expired)

 Synthon Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Amlodipine Besylate's patents.

Given below is the list recent legal activities going on the following patents of Amlodipine Besylate.

Activity Date Patent Number
Patent litigations
Expire Patent
Critical
 07 Jan, 2013 US6828339
Change in Power of Attorney (May Include Associate POA)
Critical
 16 Apr, 2007 US6828339
Correspondence Address Change
Critical
 16 Apr, 2007 US6828339
Correspondence Address Change
Critical
 09 Mar, 2005 US6828339
Recordation of Patent Grant Mailed
Critical
 07 Dec, 2004 US6828339
Patent Issue Date Used in PTA Calculation
Critical
 07 Dec, 2004 US6828339
Issue Notification Mailed
Critical
 18 Nov, 2004 US6828339
Receipt into Pubs 15 Nov, 2004 US6828339
Dispatch to FDC 11 Nov, 2004 US6828339
Receipt into Pubs 05 Nov, 2004 US6828339


Amlodipine Besylate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amlodipine Besylate Generic API Manufacturers

Several generic applications have been filed for Amlodipine Besylate. The first generic version for Amlodipine Besylate was by Mylan Pharmaceuticals Inc and was approved on Oct 3, 2005. And the latest generic version is by Sunshine Lake Pharma Co Ltd and was approved on May 4, 2018.

Given below is the list of companies who have filed for Amlodipine Besylate generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE

tablet Prescription ORAL AB Apr 29, 2013
EQ 2.5MG BASE

tablet Prescription ORAL AB Apr 29, 2013
EQ 10MG BASE

tablet Prescription ORAL AB Apr 29, 2013





2. ALKEM

Alkem Laboratories Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Alkem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Prescription ORAL AB May 4, 2009
EQ 5MG BASE

tablet Prescription ORAL AB May 4, 2009
EQ 10MG BASE

tablet Prescription ORAL AB May 4, 2009


Manufacturing Plant Locations
New

Alkem's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alkem as present at those locations.

Country City Firm Name
India
Baddi Alkem Laboratories Limited
Daman Alkem Laboratories Ltd
Navi Mumbai Alkem Laboratories Ltd., Bioequivalence Centre
Ankleshwar Alkem Laboratories Limited





3. AMNEAL PHARMS NY

Amneal Pharmaceuticals Ny Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Amneal Pharms Ny.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Jan 16, 2008
EQ 5MG BASE

tablet Discontinued ORAL N/A Jan 16, 2008
EQ 10MG BASE

tablet Discontinued ORAL N/A Jan 16, 2008





4. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Prescription ORAL AB Jul 17, 2007
EQ 10MG BASE

tablet Prescription ORAL AB Jul 17, 2007
EQ 5MG BASE

tablet Prescription ORAL AB Jul 17, 2007


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





5. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Sep 10, 2007
EQ 10MG BASE

tablet Discontinued ORAL N/A Sep 10, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Sep 10, 2007





6. CHINA RESOURCES

China Resources Saike Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by China Resources.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE

tablet Prescription ORAL AB Apr 15, 2011
EQ 10MG BASE

tablet Prescription ORAL AB Apr 15, 2011
EQ 2.5MG BASE

tablet Prescription ORAL AB May 16, 2016


Manufacturing Plant Locations
New

China Resources's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of China Resources as present at those locations.

Country City Firm Name
China
Beijing China Resources Saike Pharmaceutical Co., Ltd.
Beijing China Resources Zizhu Pharmaceutical Co., Ltd.
Shenzhen China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.





7. CIPLA

Cipla Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE

tablet Prescription ORAL AB Sep 26, 2007
EQ 2.5MG BASE

tablet Prescription ORAL AB Sep 26, 2007
EQ 10MG BASE

tablet Prescription ORAL AB Sep 26, 2007


Manufacturing Plant Locations
New

Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.

Country City Firm Name
India
Vasco Da Gama Cipla Limited
Raigad Cipla Limited
Mumbai Cipla Limited
Bengaluru Cipla Limited
Pithampur, District Dhar Cipla Limited
Bangalore Cipla Ltd.
Kurkumbh Village, Dist. Pune Cipla, Ltd.





8. COREPHARMA

Corepharma Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Corepharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Prescription ORAL AB May 23, 2007
EQ 2.5MG BASE

tablet Prescription ORAL AB May 23, 2007
EQ 5MG BASE

tablet Prescription ORAL AB May 23, 2007


Manufacturing Plant Locations
New

Corepharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Corepharma as present at those locations.

Country City Firm Name
United States
Middlesex CorePharma, LLC





9. EPIC PHARMA LLC

Epic Pharma Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Prescription ORAL AB Apr 8, 2009
EQ 5MG BASE

tablet Prescription ORAL AB Apr 8, 2009
EQ 10MG BASE

tablet Prescription ORAL AB Apr 8, 2009





10. GEDEON RICHTER USA

Gedeon Richter Usa Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Gedeon Richter Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Jul 17, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Jul 17, 2007
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Jul 17, 2007





11. GENPHARM

Genpharm Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Genpharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007
EQ 10MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007





12. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007
EQ 10MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





13. HIKMA PHARMS

Hikma Pharmaceuticals has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Hikma Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Apr 12, 2011
EQ 5MG BASE

tablet Discontinued ORAL N/A Apr 12, 2011
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Apr 12, 2011





14. INVAGEN PHARMS

Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Invagen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Prescription ORAL AB Dec 10, 2015
EQ 5MG BASE

tablet Prescription ORAL AB Dec 10, 2015
EQ 10MG BASE

tablet Prescription ORAL AB Dec 10, 2015





15. LUPIN

Lupin Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Lupin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE

tablet Prescription ORAL BX Jul 12, 2007
EQ 10MG BASE

tablet Prescription ORAL BX Jul 12, 2007
EQ 2.5MG BASE

tablet Prescription ORAL BX Jul 12, 2007


Manufacturing Plant Locations
New

Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.

Country City Firm Name
India
Navi Mumbai LUPIN LIMITED
Mandideep Lupin Limited (Unit II)
Vasco Da Gama Lupin Limited
Pithampur Lupin Limited
Aurangabad Lupin Ltd.
Pirangut Lupin Limited
Pithampur Lupin Limited (Unit 1)
Tarapur, Thane Lupin Limited
Anakapalli District Lupin Manufacturing Solutions Limited
Mumbai Lupin Limited
Mandideep Lupin Limited
Dabhasa LUPIN MANUFACTURING SOLUTIONS LIMITED
Nagpur Lupin Limited
Pune Lupin Bioresearch Center
United States
Baltimore Lupin Pharmaceuticals Inc.
Coral Springs Lupin Research Inc





16. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Apr 13, 2012
EQ 5MG BASE

tablet Discontinued ORAL N/A Apr 13, 2012





17. MYLAN

Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Oct 3, 2005
EQ 10MG BASE

tablet Discontinued ORAL N/A Oct 3, 2005
EQ 5MG BASE

tablet Discontinued ORAL N/A Oct 3, 2005


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Rockford Mylan Institutional, Inc.
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
San Carlos Mylan Pharmaceuticals Inc.
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Morgantown Mylan Specialty, L.P.
Saint Albans Mylan Technologies, Inc.
Greensboro Mylan Pharmaceuticals Inc
India
Hyderabad Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Anekal Taluk, Bangalore Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





18. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Feb 27, 2008
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Feb 27, 2008
EQ 5MG BASE

tablet Discontinued ORAL N/A Feb 27, 2008





19. ORBION PHARMS

Orbion Pharmaceuticals Private Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Orbion Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Prescription ORAL AB Jul 2, 2009
EQ 5MG BASE

tablet Prescription ORAL AB Jul 2, 2009
EQ 10MG BASE

tablet Prescription ORAL AB Jul 2, 2009





20. OXFORD PHARMS

Oxford Pharmaceuticals Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Oxford Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Prescription ORAL AB Apr 7, 2010
EQ 5MG BASE

tablet Prescription ORAL AB Apr 7, 2010
EQ 10MG BASE

tablet Prescription ORAL AB Apr 7, 2010





21. POLYGEN PHARMS

Polygen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Polygen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE

tablet Prescription ORAL AB Jul 11, 2016
EQ 10MG BASE

tablet Prescription ORAL AB Jul 11, 2016
EQ 2.5MG BASE

tablet Prescription ORAL AB Jul 11, 2016





22. PURACAP PHARM

Puracap Pharmaceutical Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Puracap Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Sep 4, 2007
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Sep 4, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Sep 4, 2007





23. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007
EQ 10MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007





24. SOVEREIGN PHARMS

Sovereign Pharmaceuticals Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sovereign Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Jul 23, 2015
EQ 5MG BASE

tablet Discontinued ORAL N/A Jul 23, 2015
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Jul 23, 2015





25. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE

tablet Prescription ORAL AB Jul 11, 2007
EQ 2.5MG BASE

tablet Prescription ORAL AB Jul 11, 2007
EQ 10MG BASE

tablet Prescription ORAL AB Jul 11, 2007


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Puducherry Strides Pharma Science Limited
Bangalore Strides Pharma Science Limited





26. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Nov 30, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Nov 30, 2007
EQ 10MG BASE

tablet Discontinued ORAL N/A Nov 30, 2007





27. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007
EQ 10MG BASE

tablet Discontinued ORAL N/A Jul 9, 2007





28. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Jan 31, 2008
EQ 5MG BASE

tablet Discontinued ORAL N/A Jan 31, 2008
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Jan 31, 2008





29. SUNSHINE

Sunshine Lake Pharma Co Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sunshine.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A May 4, 2018
EQ 5MG BASE

tablet Discontinued ORAL N/A May 4, 2018
EQ 10MG BASE

tablet Discontinued ORAL N/A May 4, 2018


Manufacturing Plant Locations
New

Sunshine's manufacturing plants are situated in 6 countries - United States, Peru, India, Thailand, China, Mozambique. Given below are the details of these plant locations as well as the firm names of Sunshine as present at those locations.

Country City Firm Name
United States
Evergreen Sunshine Honey Bees LLC
Alhambra Sunshine Bakery
Bridgeville Sunshine Burger & Specialty Food Company, LLC
North Las Vegas Sunshine Fresh Nevada LLC
Artesia Sunshine Evergreen Inc.
Tupelo Sunshine Mills, Inc.
Doral Sunshine Bottling Co, Inc.
Jacksonville Sunshine Peanut Company
Halifax Sunshine Mills, Inc.
Red Bay Sunshine Mills aka World Pet Care
Andrews Sunshine Dairy, LLC
Augusta Sunshine Honey Inc.
Rochester Sunshine Fund Raising Co.
Portland Sunshine Dairy Foods Management LLC
Indianapolis SUNSHINE INTERNATIONAL LLC
Glenwood Springs Sunshine & Moons, LLC
Dublin Sunshine Mills, Inc
Columbus Sunshine Apiaries
Maumee Sunshine Inc Of Nw Ohio
Methuen Sunshine International Foods, Inc.
Peru
Tambogrande Sunshine Export S.A.C
India
Surat Sunshine Global Hospital
Thailand
Tha Mai Sunshine International
China
Dongguan Sunshine Lake Pharma Co., Ltd
Mozambique
Boane Sunshine Nut Limitada





30. SYNTHON PHARMS

Synthon Pharmaceuticals Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Synthon Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Jun 27, 2007
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Jun 27, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Jun 27, 2007





31. TEVA

Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Prescription ORAL AB Jun 28, 2007
EQ 5MG BASE

tablet Prescription ORAL AB Jun 28, 2007
EQ 2.5MG BASE

tablet Prescription ORAL AB Jun 28, 2007


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Horsham Teva Branded Pharmaceutical Products R&D
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Fort Dodge TEVA Animal Health Inc
Miami Teva Branded Pharmaceutical Products R & D, Inc.
India
Gajraula, Amroha Teva API India Private Ltd.
Bhind Teva API India Ltd- Malanpur
Canada
Markham Teva Canada Limited
Scarborough Teva Canada Limited
Stouffville Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





32. TORRENT PHARMS

Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Torrent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Sep 22, 2008
EQ 10MG BASE

tablet Discontinued ORAL N/A Sep 22, 2008
EQ 5MG BASE

tablet Discontinued ORAL N/A Sep 22, 2008





33. UNICHEM

Unichem Laboratories Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Prescription ORAL AB Oct 21, 2013
EQ 2.5MG BASE

tablet Prescription ORAL AB Oct 21, 2013
EQ 5MG BASE

tablet Prescription ORAL AB Oct 21, 2013


Manufacturing Plant Locations
New

Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.

Country City Firm Name
India
Ghaziabad Unichem Laboratories Ltd.
Mumbai Unichem Laboratories Limited
Kolhapur Unichem Laboratories Limited
Pilerne Bardez Unichem Laboratories Limited
Pithampur Unichem Laboratories Limited
District Raigad Unichem Laboratories Ltd
United States
Hasbrouck Heights Unichem Pharmaceuticals Usa Inc
East Brunswick Unichem Pharmaceuticals USA Inc.





34. WATSON LABS

Watson Laboratories Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Jul 19, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Jul 19, 2007
EQ 10MG BASE

tablet Discontinued ORAL N/A Jul 19, 2007





35. WOCKHARDT

Wockhardt Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Wockhardt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2.5MG BASE

tablet Discontinued ORAL N/A Sep 6, 2007
EQ 10MG BASE

tablet Discontinued ORAL N/A Sep 6, 2007
EQ 5MG BASE

tablet Discontinued ORAL N/A Sep 6, 2007


Manufacturing Plant Locations
New

Wockhardt's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Wockhardt as present at those locations.

Country City Firm Name
India
Aurangabad Wockhardt Limited
Solan, Nalagarh Wockhardt Limited - Baddi
Ankleshwar Wockhardt, Ltd.





36. ZYDUS PHARMS USA

Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Prescription ORAL AB Jul 9, 2007
EQ 5MG BASE

tablet Prescription ORAL AB Jul 9, 2007
EQ 2.5MG BASE

tablet Prescription ORAL AB Jul 9, 2007